ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      62,945.58
      -1.24%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Pharming Group NV Leiden (PK) (PHGUF)

      7. Pharming Group NV Leiden (PK) (PHGUF) News

      PHGUF

      Pharming Group NV Leiden (PK) (PHGUF)

      Pharming Group NV Leiden (PK)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:PHGUF
      DateTimeSourceHeadlineSymbolCompany
      12/15/20236:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
      11/13/20239:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
      09/25/202310:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
      08/14/20238:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
      08/09/202311:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
      07/18/20236:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
      06/01/20236:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      04/11/20238:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      04/05/20236:57AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
      03/27/20231:41PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      03/16/202310:39AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      03/13/20237:34AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      03/13/20237:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      02/21/20239:43AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      02/17/202310:41AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      10/27/20226:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      08/02/20226:09AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      06/02/20228:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      05/18/202212:55PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      04/26/20227:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      04/06/20224:15PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
      04/06/20224:10PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      01/06/20227:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      01/04/20227:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      10/28/20214:18PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:PHGUFPharming Group NV Leiden (PK)
      10/28/20217:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      10/22/20217:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      09/14/20219:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
      08/09/20214:05PMEdgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:PHGUFPharming Group NV Leiden (PK)
      08/05/20217:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
       Showing the most relevant articles for your search:USOTC:PHGUF